We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $974M
1-Year Est. Return 13.43%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+13.43%
3 Year Est. Return
+53.19%
5 Year Est. Return
+76.04%
10 Year Est. Return
+263.05%
AUM
$314M
AUM Growth
+$26.3M
Cap. Flow
+$9.97M
Cap. Flow %
3.18%
Top 10 Hldgs %
30.3%
Holding
88
New
17
Increased
41
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$2.84M
2
AAPL icon
Apple
AAPL
+$556K
3
SYK icon
Stryker
SYK
+$504K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$464K
5
AMGN icon
Amgen
AMGN
+$419K

Sector Composition

Rank Sector Weight
1 Technology 24.58%
2 Healthcare 16.48%
3 Communication Services 11.71%
4 Energy 9.42%
5 Financials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.99T
$9.96M 3.18%
162,905
+4,310
+3% +$259K
CHKP icon
2
Check Point Software Technologies
CHKP
$14.1B
$9.87M 3.15%
118,491
+4,295
+4% +$352K
AAPL icon
3
Apple
AAPL
$4.8T
$9.7M 3.09%
342,180
+19,596
+6% +$556K
XOM icon
4
ExxonMobil
XOM
$615B
$9.69M 3.09%
108,599
+3,563
+3% +$311K
JPM icon
5
JPMorgan Chase
JPM
$901B
$9.59M 3.06%
112,833
+3,754
+3% +$286K
ADP icon
6
Automatic Data Processing
ADP
$102B
$9.52M 3.04%
93,804
+1,313
+1% +$123K
SYY icon
7
Sysco
SYY
$38.6B
$9.43M 3.01%
173,188
+3,934
+2% +$204K
PARA
8
DELISTED
Paramount Global Class B
PARA
$9.18M 2.93%
145,239
+1,004
+0.7% +$59.6K
T icon
9
AT&T
T
$153B
$9.15M 2.92%
289,328
+12,566
+5% +$371K
DE icon
10
Deere & Co
DE
$158B
$8.94M 2.85%
88,260
+664
+0.8% +$62.4K
JNJ icon
11
Johnson & Johnson
JNJ
$599B
$8.92M 2.84%
78,394
+2,192
+3% +$253K
ACN icon
12
Accenture
ACN
$88.6B
$8.88M 2.83%
77,009
+1,671
+2% +$198K
CACI icon
13
CACI
CACI
$9.97B
$8.84M 2.82%
72,278
-6,730
-9% -$777K
OMC icon
14
Omnicom Group
OMC
$23.5B
$8.83M 2.82%
105,467
+4,318
+4% +$362K
SYK icon
15
Stryker
SYK
$122B
$8.82M 2.81%
74,639
+4,377
+6% +$504K
BHI
16
DELISTED
Baker Hughes
BHI
$8.61M 2.74%
134,358
+3,390
+3% +$201K
DD icon
17
DuPont de Nemours
DD
$18.3B
$8.57M 2.73%
60,186
+1,359
+2% +$189K
TRV icon
18
Travelers Companies
TRV
$78.4B
$8.55M 2.73%
71,009
+2,038
+3% +$233K
CE icon
19
Celanese
CE
$4.89B
$8.51M 2.71%
109,449
+713
+0.7% +$53.6K
ELV icon
20
Elevance Health
ELV
$82.9B
$8.44M 2.69%
59,739
-358
-0.6% -$47.9K
RVTY icon
21
Revvity
RVTY
$11.9B
$8.32M 2.65%
161,736
+2,977
+2% +$156K
AMGN icon
22
Amgen
AMGN
$197B
$8.18M 2.61%
56,584
+2,785
+5% +$419K
IBM icon
23
IBM
IBM
$200B
$7.97M 2.54%
50,850
+1,130
+2% +$172K
TROW icon
24
T. Rowe Price
TROW
$25B
$7.62M 2.43%
103,120
+2,689
+3% +$191K
APA icon
25
APA Corp
APA
$12.3B
$7.53M 2.4%
120,357
+2,238
+2% +$141K

Similar funds

Steigerwald Gordon & Koch's Q4 2016 Portfolio in Review

As of Q4 2016, Steigerwald Gordon & Koch held 88 positions worth $314M, up 9.1% from $287M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Steigerwald Gordon & Koch deployed $9.97M of net new capital in Q4 2016, opening 17 new positions and adding to 41 existing holdings. Its largest new stake was CDK Global, Inc.: 49,576 shares worth $2.92M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was NextGen Healthcare, Inc. Common Stock, an estimated $1.23M trimmed.

  • Steigerwald Gordon & Koch's largest Q4 2016 buy was CDK Global, Inc.: 49,576 shares worth $2.92M.
  • Steigerwald Gordon & Koch added most to Apple in Q4 2016, an estimated $556K increase.
  • Steigerwald Gordon & Koch's biggest Q4 2016 reduction was NextGen Healthcare, Inc. Common Stock, cutting an estimated $1.23M.
  • Steigerwald Gordon & Koch fully exited AB InBev in Q4 2016, selling an estimated $384K.
  • Steigerwald Gordon & Koch's ten largest holdings make up 30% of its $314M portfolio in Q4 2016.
  • Steigerwald Gordon & Koch opened 17 new positions and closed 3 in Q4 2016.
  • Steigerwald Gordon & Koch's portfolio value rose 9.1% quarter-over-quarter to $314M.

Based on Steigerwald Gordon & Koch's 13F filing for Q4 2016, filed 13 Sep 2018.